logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Investing as Shakespearean Tragedy: The Story of Ariad Pharmaceutical (ARIA)

By  +Follow November 12, 2013 8:57AM
Share:
Tickers Mentioned:

Shares in Ariad Pharmaceuticals (ARIA) were up 10.78 percent on Veterans Day. Even for a small-cap like Ariad, coming in at a valuation just under a half billion dollars, that’s normally what one would consider a pretty solid bounce. That’s a day that, for a lot of investors, would stand out. However, for the battered shareholders of Ariad, it probably doesn’t even register any more. Okay, that’s not true, double-digit jumps always register. But after the Odyssey Ariad’s been on for the last month, it’s not difficult to imagine that days like Monday just get lost in the shuffle.

It’s not often you see a company go on a ride like Ariad just has, plunging sharply, appearing to rally, rinse and repeat. And it’s a drama that’s swept a lot of people up. Over the last 3 months, Ariad’s moved an average of 11.14 million shares a day, good to make it the 75th most traded security over that period, one spot behind Elon Musk’s Tesla Motors (TSLA) , a battleground stock and the source of general market fascination. That’s a class that contains mostly mega-cap blue chips and high-profile ETFS, relatively few small-cap companies. And that’s not even the whole story. Ariad’s heavy volume is drawn mostly from the massive spike this last month. Over the last 30 days Aria has been moving an average of 20 million shares a day, meaning that more than 10 percent of outstanding shares are trading hands on an average day.

So what’s happening with this company? The story’s a simple one, but, for Ariad investors, it’s a tragic one.

Volatile Month

Lets start with the whole story: since the start of October, Ariad Pharmaceutical’s stock has lost over 85 percent of its value. No matter how specifically you pull things apart, that’s the simple fact one cannot avoid. Especially if you’ve owned Ariad for that whole stretch. But inside that one big sell-off is a series of daily price moves that could drive an investor insane. Here’s a timeline or the events that have brought Ariad so much grief:

October 8:

After market close, news gets out regarding the clinical trials for Ariad’s leukemia drug Iclusig and it’s bad. In fact, if you’re long Ariad, it’s positively awful. The drug showed blood clots developing in 11.8 percent of people treated with Iclusig after 24 months. This was a big jump from the 8 percent rate found after 11 months, and it prompts the FDA to block Ariad from enrolling any new patients to drug trials for Iclusig.

Like most small-cap pharma companies, Ariad’s future is tied mainly to just a couple of drugs, and the news that one of them might not be safe is pretty drastic. Especially when one considers that the nearly 800 percent gains from the start of 2010 to October 7 had a lot to do with the fact that Iclusig looked so promising, even getting accelerated approval based on its Phase 2 clinical data.

So it shouldn’t be surprising that the market’s reaction was swift and vengeful. As soon as investors got a crack at selling their position on October 9 shares plummeted over 65 percent.

October 10-18:

If the story ended there, it would be pretty much in line with a familiar narrative: small-cap pharma plummets on negative results of clinical trial. But, while nothing matched the degree of the move on the ninth, Ariad kept trading at heavy volumes and kept posting double-digit moves.

A series of analyst downgrades hit the company on October 10, with Barclays (BCS) downgrading the stock from overweight to underweight and cutting the price target from $25 a share to $4 (ouch). The stock kept falling, losing another 30 percent from October 10-16 but coasting into what appeared to be a bottom on October 16.

Then, on October 17, signs of life! Following comments from JP Morgan (JPM) analyst Cory Kasimov that physicians may not be all that concerned about the blood clots, the stock rebounded, posting a 10.78 percent gain and potentially giving hope to Ariad owners that the worst was behind them.

Except that it wasn’t. Not at all. October 18, word came out that Ariad and the FDA had agreed to halt testing of Iclusig entirely based on the rate of blood clotting incidences. The discontinuation of the late-stage trial dubbed Epic by Ariad caused shares to plunge more than 40 percent that day.

October 21-October 30:

After any stock gets hammered that hard in that short a period, one might expect it to bounce back. At least a little. Considering how steep the discount it’s trading at as compared to a mere two weeks ago, it has to garner at least a little interest, right?

And it did. The company staged a pretty substantial rally, gaining almost 50 percent in just nine days. It’s not much when one considers just how fall the stock fell prior to the rally, but at least the battered shareholders got a respite in the end, right?

October 31:

Only it wasn’t the end. Halloween was extra spooky if you had decided to wait out Ariad’s steep decline. Ariad announced that it would suspend marketing and distribution of Iclusig while it "continues to negotiate updates to the U.S. prescribing information." In retrospect, it certainly seems as though this shouldn’t have been all that surprised, but it clearly surprised at least some people as the company’s stock plunged nearly 45 percent.

And Beyond…?

Where Ariad’s going from here is unclear. Since the start of November, the stock’s up over 15 percent, including a 17.27 percent leap the day after Halloween and Monday’s double-digit gain. However, precisely what to expect moving forward is unclear. In the event that Ariad can return Iclusig to the market and ensure that it’s safe, there’s a pretty good chance the stock takes off. That said, there’s no real way to know whether or not that’s possible. In the meantime, the company announced that it was shedding 40 percent of its American-based workforce on November 7.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for ARIA
Anmol Singh
5 Mar 15 06:29:42
Biotechs will be ''in-play'' today $IBB $ARIA $PCYC $BIIB $CELG
Stockguy22
5 Mar 15 06:15:15
#premarket Up $COST $SFM $PCYC $BABA $KR $ICPT $LL $DNKN $MAC $ADXS $JUNO $CSIQ $ARIA $EYES $ZIOP Down $ABBV $SSL $COMM $CAT $CAPN $BRLI
Jack Trader
5 Mar 15 06:02:57
$ARIA Analyst Rating Update on ARIAD Pharmaceuticals, Inc. http://t.co/2GJX5Zl8X3
Stock Rocket
5 Mar 15 06:02:36
Check out http://t.co/5jbX6lWXsj. They have a cool and different way of doing trade alerts. Pretty cool. $CDE $GNW $LPI $SVU $ARIA $CYTR
Stock Signaling
5 Mar 15 06:01:02
Pre-Market Price Advances: $OREX $PCYC $CSIQ $CLDX $INSM $ARWR $ARIA $YNDX $REXX $KNDI $SFM $LINE http://t.co/DEd0xkdNq4 #trader #nyse #spy
Christopher Angus
5 Mar 15 06:00:03
Premarket most advanced stocks: $KYTH, $CLDN, $ARWR, $PCYC, $CSIQ, $KITE, $INSM, $ARIA, $CLDX, $SGYP
Whack The Bid
5 Mar 15 05:59:17
Bloomberg notes shares of Stocks Indicated Higher $AVEO +13% $ZIOP +5% $JUNO +3% $INSM +3.3% $ARIA +3.5% $CLDX +2.4%
Shred Bundy
5 Mar 15 05:56:51
My main 6 : $NAVB $EYES $CLDN $OREX $PEIX $ARIA alot of action so far in premarket should be fun.
Anmol Singh
5 Mar 15 05:53:00
Focus List for today $PEIX $TGTX $GDOT $ARIA $COST $EXAS $ANF $CENX $FLWS
John Smith
5 Mar 15 05:46:47
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv $mrk $gsk $azn #cncb $aezs $pfe $nbik $itek $shpg $arry $c $exas
John Smith
5 Mar 15 05:42:21
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv $mrk $gsk $azn #cncb $aezs $pfe $gs $ctic $shpg $jpm $c $$$
Drew Powers
5 Mar 15 05:40:54
Watching this morning; $UVXY $CTIC $MSTX longs and $ARIA $GENE $ONCY $CYTX short - g/l today!
Penny Stock Secret
5 Mar 15 05:36:57
Replicate Multimillionaire Strategy Easy to Copy! Subscription is Cheap! http://t.co/SVqoMkrw2z ..$FASC $ARIA $TUCN
John Smith
5 Mar 15 05:35:09
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv $mrk $gsk $azn #cncb $aezs $pfe $gs $ctic $shpg $jpm $c $
John Smith
5 Mar 15 05:31:44
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv $mrk $gsk $azn #cncb $aezs $pfe $gs $ctic $shpg $jpm $ $exas $aapl
RF2009
5 Mar 15 05:31:42
$ARIA perking
John Smith
5 Mar 15 05:29:52
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv $mrk $gsk $azn #cncb $aezs $pfe $gs $ctic $shpg $jpm $c $exas
John Smith
5 Mar 15 05:29:36
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv $mrk $gsk $azn #cncb $aezs $pfe $gs $ctic $shpg $jpm $c
John Smith
5 Mar 15 05:27:37
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv $mrk $gsk $azn #cncb $aezs $pfe $gs $ctic
John Smith
5 Mar 15 05:14:19
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv $mrk $gsk $azn #cncb
John Smith
5 Mar 15 05:10:45
Will $ARIA now be acquired by $jnj after failed $pcyc acquisition? $abbv
E-Train
5 Mar 15 05:03:19
$ARIA Might see a boost from $PCYC BUYOUT. http://t.co/v5UxYI6Zox
Russell Barbour
5 Mar 15 05:00:14
51% profit Super win! $CRMD momentum trade: http://t.co/qM5oWhbLjM $ARIA $GREK $CYBR $MBLY $SPPI $NDLS $PANW $HACK
BreakingStocksNews
5 Mar 15 04:06:04
$OAS $OREX $ARIA: Watch List: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Oasis ...: http://t.co/DzYXUxixtt
1st Penny Stocks
5 Mar 15 03:22:36
RT @JumpyStocks: Daily watchlist $GPRO $DAKP $ARCP $ARIA $PAL http://t.co/snD3L9qkox
Charles G. Koonitz
5 Mar 15 03:21:29
Daily watchlist $GPRO $DAKP $ARCP $ARIA $PAL http://t.co/snD3L9qkox
Trader News Daily
5 Mar 15 02:52:26
Wow http://t.co/PeRPkYu8Uk just posted last weeks results. +429%. Crazy. They offer a free trial too. $BSBR $ARIA $GALE $NBG $MHR
BreakingStocksNews
5 Mar 15 02:31:02
$ARIA: Analyst Rating Update on ARIAD Pharmaceuticals, Inc.: http://t.co/6syLk4XBI9
Wall Street
5 Mar 15 02:22:45
http://t.co/iQWRYq6dIh will not help you lose weight...but it will help you make money trading. Enjoy! $ARIA $MYEC $SWET
Stockaholics
5 Mar 15 01:44:21
400% Gains On Our Stock Picks & a MASSIVE New Pick Coming today! Check it out: http://t.co/IL8yCE0CRE $FASC $ARIA $TUCN
Katsu
5 Mar 15 00:18:47
$ARIA b/o watch
Greg David
4 Mar 15 22:07:15
http://t.co/RMvVXnJDpv does trade alerts differently than anyone else. Its super cool. $ARIA $HT $CIM $BAS $ARNA
Trader News Daily
4 Mar 15 21:56:57
Wow http://t.co/PeRPkYu8Uk just posted last weeks results. +429%. Crazy. They offer a free trial too. $BSBR $ARIA $GALE $NBG $MHR
Stock Rocket
4 Mar 15 18:44:07
Thanks to the 5 pro traders at http://t.co/5jbX6lWXsj for an amazing week! My win rate was 80%. So sweet. $ARIA $GNBT $CIG $NVAX
vivarod
4 Mar 15 18:01:36
$CZR judge in car bankruptcy allowed two pending cases against CEOC to proceed. $AMBC, $FNMA , $ARIA, @FNMA , #FNMA
Sam
4 Mar 15 16:20:09
A few more of interest: $AMBA $ADXS $AAL $AMGN $AMZN $ARIA $ARRY $ASHR http://t.co/bh923uwZvq http://t.co/NavhbtS3s6
Rosner Stocks
4 Mar 15 15:26:30
$TWTR Last Price Updated Wednesday, March 4, 2015 5:59:24 PM $OIH $BAC $ABX $ARIA http://t.co/CdU7FvjVEC
Rosner Stocks
4 Mar 15 14:43:14
Stocks Trending Now: http://t.co/0kBSoP98fd $COS.TO $XEC $HNU.TO $ARIA $SOXL $CUT $XOM $NKE $XLY $ICPT $LUV $IYR ~
Mark Trader
4 Mar 15 14:31:09
http://t.co/U0VrKn1h21 has the most reliable picks in the market. The move fast and never fail. $WEN $SPF $NLY $GFI $SRC $ARIA
Sourcingstocks.com
4 Mar 15 14:30:00
$CYCC should bounce tomorrow in the AM and $ARIA goes much higher - we think @ http://t.co/QWguO6vOGl
Rosner Stocks
4 Mar 15 14:24:37
$VXX Stock Price Updated Wednesday, March 4, 2015 4:59:23 PM $ARIA $XLK $TVIX $ITB http://t.co/4QBfRy4QgC
Sourcingstocks.com
4 Mar 15 14:23:02
$ARIA is set to shine @ http://t.co/6KKhwx2Mwp -#NASDAQ, #biotech
Langan Stocks
4 Mar 15 14:20:03
$ANY Percent Change Updated Wednesday, March 4, 2015 5:03:20 PM $C $TSLA $ARIA $XOM http://t.co/DjUa7cw1Qw
Jersey Drew
4 Mar 15 14:12:35
RT @hedgefundclone: One of them is Alex Denner of Sarissa, Yale PhD and former head of Icahn's Healthcare Investments also the man behind $…
BillionairesPort
4 Mar 15 14:12:02
One of them is Alex Denner of Sarissa, Yale PhD and former head of Icahn's Healthcare Investments also the man behind $ARIA and Idenix
Irma Doucet
4 Mar 15 14:01:57
$ARIA A Stock Report on Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) http://t.co/53pytRR4Y6
Samuel Brown
4 Mar 15 14:01:54
$ARIA Why Ariad Pharmaceuticals, Inc. Stock Soared Higher Today http://t.co/3gUk3QYprs
Penny Stock Secret
4 Mar 15 13:55:27
Yesterday We Made $89,000 In Just One Trade More Info Here http://t.co/NovWYe2RAx .. $INSY $SIGI $ARIA
Phil Martin
4 Mar 15 13:41:16
$ARIA http://t.co/Y4Ne0X3yvY
BillionairesPort
4 Mar 15 13:37:03
@naufalsanaullah nice trading on both $ARIA and $AEO, like I always said I have never lost money following insider buying over $1mn $AEO
				
				
By  +Follow November 12, 2013 8:57AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.